Dyne Therapeutics, Inc. Detailed Financials
Full historical quarterly statements
| Metric | 2026-03-31 | 2025-12-31 | 2025-09-30 | 2025-06-30 | 2025-03-31 | 2024-12-31 | 2024-09-30 | 2024-06-30 |
|---|---|---|---|---|---|---|---|---|
| Total Revenue | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Cost of Goods Sold | 550K | 521K | 0 | 0 | 0 | 0 | 0 | 0 |
| Gross Profit | -550K | -521K | 0 | 0 | 0 | 0 | 0 | 0 |
| R&D Expenses | 100.9M | 95.4M | 97.2M | 99.2M | 106.4M | 81.8M | 92.8M | 62.3M |
| Operating Expenses | 125.3M | 115.6M | 113.9M | 115.8M | 122.4M | 97.1M | 105.7M | 72.0M |
| Operating Income | -125.3M | -116.1M | -113.9M | -115.8M | -122.4M | -97.1M | -105.7M | -72.0M |
| Other Income / Gains | 4.4M | 4.2M | 5.9M | 4.9M | 7.0M | 7.6M | 8.5M | 6.9M |
| Net Income | -120.9M | -112.0M | -108.0M | -110.9M | -115.4M | -89.5M | -97.1M | -65.1M |
| EPS (Diluted) | -0.73 | -0.76 | -0.76 | -0.97 | -1.05 | -0.88 | -0.96 | -0.70 |
| Reported Currency | USD | USD | USD | USD | USD | USD | USD | USD |
| Gross Profit Ratio | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| General And Administrative Expenses | 24.4M | 20.7M | 16.7M | 16.6M | 15.9M | 15.3M | 12.9M | 9.7M |
| Selling And Marketing Expenses | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Selling General And Administrative Expenses | 24.4M | 20.7M | 16.7M | 16.6M | 15.9M | 15.3M | 12.9M | 9.7M |
| Other Expenses | 0 | -521K | 0 | 0 | 0 | 0 | 0 | 0 |
| Cost And Expenses | 125.3M | 116.1M | 113.9M | 115.8M | 122.4M | 97.1M | 105.7M | 72.0M |
| Interest Income | 8.8M | 7.7M | 8.5M | 6.6M | 7.1M | 7.6M | 9.3M | 7.1M |
| Interest Expense | 4.2M | 3.2M | 2.9M | 94K | 0 | 0 | 0 | 0 |
| Depreciation And Amortization | 550K | 521K | 523K | 503K | 502K | 450K | 438K | 399K |
| Ebitda | -125.3M | -101.2M | -104.6M | -110.3M | -121.9M | -96.7M | -105.2M | -64.7M |
| Ebitdaratio | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Operating Income Ratio | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Income Before Tax | -120.9M | -112.0M | -108.0M | -110.9M | -115.4M | -89.5M | -97.1M | -65.1M |
| Income Before Tax Ratio | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Income Tax Expense | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Net Income Ratio | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Epsdiluted | -0.73 | -0.76 | -0.76 | -0.97 | -1.05 | -0.88 | -0.96 | -0.70 |
| Weighted Average Shs Out | 165.0M | 128.4M | 141.8M | 113.9M | 109.9M | 102.0M | 100.9M | 92.5M |
| Weighted Average Shs Out Dil | 165.0M | 128.4M | 141.8M | 113.9M | 109.9M | 102.0M | 100.9M | 92.5M |